Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$2.55M-$2.55MderivedN/M vs Q4 2019 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$2,551,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,592,000N/M ended Dec 31, 2020 · filed Mar 9, 2021 · 68 d after period end